Agora’s Latest – “Agora Financial’s FDA Trader”

Agora is claiming a ”flaw” in the stock market via the ”PDUFA” (an acronym that originated with the Prescription Drug User Fee Act) that allows them to know in advance a ”magic” date that the FDA will reveal critical information about a certain drug’s approval or disapproval status. To quote Agora, ”during the review process […]